Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions | MicrobiomeTrials← Back to trialsNCT03492151
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
RecruitingOBSERVATIONAL
Trial Details
Start: 2018-10-01Est. Completion: 2026-12-31
Enrollment target: 500 participants Locations- Mayo Clinic Scottsdale Campus, Scottsdale, Arizona, United States
- Stanford Hospital, Stanford, California, United States
- Yale School of Medicine, New Haven, Connecticut, United States
- Parkview Hospital Randallia, Fort Wayne, Indiana, United States
- The Johns Hopkins Hospital, Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
- NYU Langone Health, Garden City, New York, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- The Ohio State University Wexner Medical Center, Columbus, Ohio, United States
- Baylor College of Medicine, Houston, Texas, United States
Other microbiome trials you might be interested in
Pancreatic Cancer
This investigation aims to demonstrate the feasibility of the lbFNA device for the first time in pancreatic cysts in hum…
Umeå, SwedenEst. completion Mar 2028
IPMNIPMN, Pancreatic
This is a multi-center randomized double-blind placebo controlled trial of patients with high-risk intraductal papillary…
Baltimore, United StatesEst. completion Jul 30, 2026
The purpose of this study is to compare two approaches for monitoring pancreatic cysts as well as to identify associated…
Birmingham, United StatesEst. completion Nov 11, 2034